IOL Chemicals and Pharmaceuticals has reported results for second quarter ended September 30, 2022.
The company has reported a fall of 49.19% in its net profit at Rs 15.67 crore for the quarter under review as compared to Rs 30.84 crore for the same quarter in the previous year. Total income of the company decreased by 0.35% at Rs 546.47 crore for Q2FY23 as compared Rs 548.39 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 68.54% in its net profit at Rs 15.91 crore for the quarter under review as compared to Rs 50.58 crore for the same quarter in the previous year. Total income of the company decreased by 51.06% at Rs 546.48 crore for Q2FY23 as compared Rs 1116.65 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |